This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Combined Pap/HPV screening for cervical cancer worth the extra cost. Pharmacoecon. Outcomes News 363, 5 (2002). https://doi.org/10.1007/BF03279074
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279074